This suggests a compensatory mechanism through which cancer cells may enhance ERRα activity under oxygen deprivation, as PGC-1α is a potent coactivator that amplifies ERRα-driven transcriptional responses [37,38]. The gene discussed is PPARGC1A; the disease is cancer.